Xr Securities LLC Moderna, Inc. Transaction History

Xr Securities LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$85.37 - $115.44 $160,495 - $217,027	1,880 New	1,880 $200,000
Q3 2023 Oct 26, 2023	BUY	$96.41 - $126.61 $308,029 - $404,518	3,195 New	3,195 $330,000
Q4 2022 Jan 03, 2023	BUY	$118.38 - $210.04 $749,108 - $1.33 Million	6,328 Added 119.13%	11,640 $2.09 Million
Q3 2022 Oct 18, 2022	BUY	$118.07 - $194.18 $109,805 - $180,587	930 Added 21.22%	5,312 $628,000
Q2 2022 Jul 14, 2022	BUY	$117.13 - $176.59 $52,591 - $79,288	449 Added 11.42%	4,382 $626,000
Q1 2022 Apr 14, 2022	SELL	$126.46 - $235.05 $1.51 Million - $2.82 Million	-11,980 Reduced 75.28%	3,933 $677,000
Q4 2021 Jan 10, 2022	BUY	$225.82 - $368.51 $1.54 Million - $2.51 Million	6,820 Added 75.0%	15,913 $4.04 Million
Q3 2021 Oct 14, 2021	BUY	$221.9 - $484.47 $1.05 Million - $2.3 Million	4,745 Added 109.13%	9,093 $3.5 Million
Q2 2021 Jul 26, 2021	SELL	$129.91 - $234.98 $640,456 - $1.16 Million	-4,930 Reduced 53.14%	4,348 $1.02 Million
Q1 2021 Apr 29, 2021	BUY	$109.18 - $185.98 $186,697 - $318,025	1,710 Added 22.6%	9,278 $1.22 Million
Q4 2020 Jan 13, 2021	BUY	$65.74 - $169.86 $497,520 - $1.29 Million	7,568 New	7,568 $791,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Xr Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Xr Securities LLC with notifications on news.